The FCA Payback on Medicare Overpayments
Client Alert | less than 1 min read | 03.07.16
In February, the Centers for Medicare & Medicaid Services issued a final rule governing the reporting and return of overpayments for items and services reimbursed under Medicare Parts A and B. A new alert discusses how the final rule clarifies when an overpayment has been identified and how efforts precedent to identifying such overpayments will be important to future enforcement efforts under the FCA.
Contacts
Insights
Client Alert | 4 min read | 04.08.26
Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years — and the agency is putting that authority to work. From the launch of a new adverse event reporting tool to forthcoming rules on fragrance allergens and good manufacturing practices (GMP), FDA is reshaping the regulatory landscape for manufacturers, packers, and distributors of cosmetic and personal care products.
Client Alert | 11 min read | 04.08.26
Client Alert | 3 min read | 04.07.26
Answering the Top Seven Questions About Pending Section 301 Deadlines
